{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:11:24Z","timestamp":1769595084772,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301765"],"award-info":[{"award-number":["81301765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672896"],"award-info":[{"award-number":["81672896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project of Zhenjiang City for Health Science and Technology","award":["SH2016038"],"award-info":[{"award-number":["SH2016038"]}]},{"name":"Project of Young Medical Talents in Jiangsu Province","award":["QNRC2016829"],"award-info":[{"award-number":["QNRC2016829"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10120-019-00962-8","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T18:04:55Z","timestamp":1555351495000},"page":"1121-1129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer"],"prefix":"10.1007","volume":"22","author":[{"given":"Xiaohui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-312X","authenticated-orcid":false,"given":"Deqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"962_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"962_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"962_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"962_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/cr.2007.115","volume":"18","author":"GM Li","year":"2008","unstructured":"Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18:85\u201398.","journal-title":"Cell Res"},{"key":"962_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247\u201357.","journal-title":"N Engl J Med"},{"key":"962_CR6","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28:3219\u201326.","journal-title":"J Clin Oncol"},{"key":"962_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ijc.26399","volume":"131","author":"JY An","year":"2012","unstructured":"An JY, Kim H, Cheong JH, Hyung WJ, Kim H, Noh SH. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer. 2012;131:505\u201311.","journal-title":"Int J Cancer"},{"key":"962_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002803","author":"YY Choi","year":"2018","unstructured":"Choi YY, Kim H, Shin SJ, Kim HY, Lee J, Yang HK, et al. Microsatellite instability and programmed cell death-ligand 1 expression in stage II\/III gastric cancer: post hoc analysis of the classic randomized controlled study. Ann Surg. 2018. \n                    https:\/\/doi.org\/10.1097\/sla.0000000000002803\n                    \n                  .","journal-title":"Ann Surg"},{"key":"962_CR9","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1245\/s10434-009-0580-8","volume":"16","author":"E Oki","year":"2009","unstructured":"Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, et al. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol. 2009;16:2510\u20135.","journal-title":"Ann Surg Oncol"},{"key":"962_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ijc.29449","volume":"137","author":"SY Kim","year":"2015","unstructured":"Kim SY, Choi YY, An JY, Shin HB, Jo A, Choi H, et al. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: results from a large cohort with subgroup analyses. Int J Cancer. 2015;137:819\u201325.","journal-title":"Int J Cancer"},{"key":"962_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4942","author":"R Cohen","year":"2018","unstructured":"Cohen R, Hain E, Buhard O, Guilloux A, Bardier A, Kaci R, et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status. JAMA Oncol. 2018. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2018.4942\n                    \n                  .","journal-title":"JAMA Oncol"},{"key":"962_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.humpath.2010.03.003","volume":"41","author":"L Klarskov","year":"2010","unstructured":"Klarskov L, Ladelund S, Holck S, Roenlund K, Lindebjerg J, Elebro J, et al. Interobserver variability in the evaluation of mismatch repair protein immunostaining. Hum Pathol. 2010;41:1387\u201396.","journal-title":"Hum Pathol"},{"key":"962_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24:1449\u201358.","journal-title":"Nat Med"},{"key":"962_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/bjs.10663","volume":"105","author":"K Polom","year":"2018","unstructured":"Polom K, Marano L, Marrelli D, De Luca R, Roviello G, Savelli V, et al. Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer. Br J Surg. 2018;105:159\u201367.","journal-title":"Br J Surg"},{"key":"962_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10689-015-9803-2","volume":"14","author":"MF Hansen","year":"2015","unstructured":"Hansen MF, Johansen J, Bj\u00f8rnevoll I, Sylvander AE, Steinsbekk KS, S\u00e6trom P, et al. A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine. Fam Cancer. 2015;14:437\u201348.","journal-title":"Fam Cancer"},{"key":"962_CR16","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/humu.20796","volume":"29","author":"I Tournier","year":"2008","unstructured":"Tournier I, Vezain M, Martins A, Charbonnier F, Baert-Desurmont S, Olschwang S, et al. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum Mutat. 2008;29:1412\u201324.","journal-title":"Hum Mutat"},{"key":"962_CR17","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.canep.2012.02.003","volume":"36","author":"D Wang","year":"2012","unstructured":"Wang D, Zhou J, Wang T, Li X, Li S, Chen S, et al. Polymorphisms in MSH2 gene and risk of gastric cancer, and interactions with lifestyle factors in a Chinese population. Cancer Epidemiol. 2012;36:e171\u20136.","journal-title":"Cancer Epidemiol"},{"key":"962_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.gene.2015.12.050","volume":"579","author":"H Zhu","year":"2016","unstructured":"Zhu H, Li X, Zhang X, Chen D, Li D, Ren J, et al. Polymorphisms in mismatch repair genes are associated with risk and microsatellite instability of gastric cancer, and interact with life exposures. Gene. 2016;579:52\u20137.","journal-title":"Gene"},{"key":"962_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/jnci\/djk095","volume":"99","author":"S Raptis","year":"2007","unstructured":"Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, et al. MLH1-93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst. 2007;99:463\u201374.","journal-title":"J Natl Cancer Inst"},{"key":"962_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.7314\/APJCP.2012.13.3.901","volume":"13","author":"JL Xu","year":"2012","unstructured":"Xu JL, Yin ZQ, Huang MD, Wang XF, Gao W, Liu LX, et al. MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies. Asian Pac J Cancer Prev. 2012;13:901\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"962_CR21","first-page":"2289","volume":"56","author":"L Xia","year":"1996","unstructured":"Xia L, Shen W, Ritacca F, Mitri A, Madlensky L, Berk T, et al. A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. Cancer Res. 1996;56:2289\u201392.","journal-title":"Cancer Res"},{"key":"962_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/1055-9965.EPI-05-0834","volume":"15","author":"CY Jung","year":"2006","unstructured":"Jung CY, Choi JE, Park JM, Chae MH, Kang HG, Kim KM, et al. Polymorphisms in the hMSH2 gene and the risk of primary lung cancer. Cancer Epidemiol Biomark Prev. 2006;15:762\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"962_CR23","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/1055-9965.EPI-06-0257","volume":"15","author":"ME Beiner","year":"2006","unstructured":"Beiner ME, Rosen B, Fyles A, Harley I, Pal T, Siminovitch K, et al. Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol Biomark Prev. 2006;15:1636\u201340.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"962_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3892\/etm.2011.336","volume":"2","author":"S Wu","year":"2011","unstructured":"Wu S, Chen J, Ji Y, Liu Y, Gao L, Chen G, et al. Association between the hMSH2 IVS12-6 T\u2009>\u2009C polymorphism and cancer risk: A meta-analysis. Exp Ther Med. 2011;2:1193\u20138.","journal-title":"Exp Ther Med"},{"key":"962_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/annonc\/mdp338","volume":"21","author":"JG Kim","year":"2010","unstructured":"Kim JG, Chae YS, Sohn SK, Moon JH, Kang BW, Park JY, et al. IVS10\u2009+\u200912A\u2009>\u2009G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer. Ann Oncol. 2010;21:525\u20139.","journal-title":"Ann Oncol"},{"key":"962_CR26","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.2008.20.1111","volume":"27","author":"X Dong","year":"2009","unstructured":"Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, et al. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. J Clin Oncol. 2009;27:1592\u20139.","journal-title":"J Clin Oncol"},{"key":"962_CR27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1089\/dna.2018.4224","volume":"37","author":"X Zhu","year":"2018","unstructured":"Zhu X, Wang Z, Qiu X, Wang W, Bei C, Tan C, et al. Rs2303428 of MSH2 is associated with hepatocellular carcinoma prognosis in a Chinese population. DNA Cell Biol. 2018;37:634\u201341.","journal-title":"DNA Cell Biol"},{"key":"962_CR28","first-page":"433","volume":"40","author":"J Yang","year":"2018","unstructured":"Yang J, Wang X, Zou SM, Li HM, Xiao Q, Feng YR, et al. Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy. Zhonghua Zhong Liu Za Zhi. 2018;40:433\u201340.","journal-title":"Zhonghua Zhong Liu Za Zhi."},{"key":"962_CR29","doi-asserted-by":"publisher","first-page":"29538","DOI":"10.18632\/oncotarget.25268","volume":"9","author":"GAS Nogueira","year":"2018","unstructured":"Nogueira GAS, Costa EFD, Lopes-Aguiar L, Lima TRP, Visacri MB, Pincinato EC, et al. Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients. Oncotarget. 2018;9:29538\u201347.","journal-title":"Oncotarget"},{"key":"962_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356.","journal-title":"Nat Med"},{"issue":"2146\u20132157","key":"962_CR31","first-page":"e12","volume":"139","author":"JC Li","year":"2010","unstructured":"Li JC, Yang XR, Sun HX, Xu Y, Zhou J, Qiu SJ, et al. Up-regulation of Kr\u00fcppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology. 2010;139(2146\u20132157):e12.","journal-title":"Gastroenterology"},{"key":"962_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","volume":"35","author":"AN Bartley","year":"2017","unstructured":"Bartley AN, Washington MK, Colasacco C, Ventura CB, Ismaila N, Benson AB III, et al. HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology. J Clin Oncol. 2017;35:446\u201364.","journal-title":"J Clin Oncol"},{"key":"962_CR33","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1200\/JCO.2014.58.3930","volume":"33","author":"SH Park","year":"2015","unstructured":"Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM, et al. Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol. 2015;33:3130\u20136.","journal-title":"J Clin Oncol"},{"key":"962_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","volume":"15","author":"SH Noh","year":"2014","unstructured":"Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15:1389\u201396.","journal-title":"Lancet Oncol"},{"key":"962_CR35","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.1038\/ncomms14418","volume":"8","author":"NQ Liu","year":"2017","unstructured":"Liu NQ, Ter Huurne M, Nguyen LN, Peng T, Wang SY, Studd JB, et al. The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression. Nat Commun. 2017;8:14418.","journal-title":"Nat Commun"},{"key":"962_CR36","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/cncr.20966","volume":"103","author":"MA Kim","year":"2005","unstructured":"Kim MA, Lee HS, Yang HK, Kim WH. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer. 2005;103:1439\u201346.","journal-title":"Cancer"},{"key":"962_CR37","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/gutjnl-2015-309340","volume":"65","author":"N Hu","year":"2016","unstructured":"Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, et al. Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut. 2016;65:1611\u20138.","journal-title":"Gut"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-019-00962-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:02:32Z","timestamp":1586908952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-019-00962-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1007\/s10120-019-00962-8","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"20 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statement"}},{"value":"Informed consent to be included in the study, or the equivalent, was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}